iRhythm Technologies, Inc. (IRTC) financial statements and ratios from SEC XBRL: revenue $747.14M (TTM), net margin -6.0%, revenue growth 26.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $747.14M |
| Net Margin | -6.0% |
| Revenue Growth (YoY) | 26.2% |
| EPS Growth (YoY) | -61.7% |
| FCF Growth (YoY) | -213.0% |
| Price / Book | 22.66 |
| Price / Sales | 5.17 |
| FCF Yield | -1.0% |
| Altman Z-Score | 2.95 (grey) |
| Sector P/E (Healthcare) | 21.6 |
IRTC overview · IRTC earnings · IRTC KPIs · IRTC investor relations · IRTC ownership · IRTC peers · IRTC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.